Common antibiotic could help stroke survivors walk again
NCT ID NCT07594301
First seen May 21, 2026
Summary
This study tests whether the antibiotic minocycline can improve recovery in people who have had a severe stroke in the back of the brain and underwent a procedure to remove a blood clot. About 234 participants will receive either minocycline or a placebo within 24 hours of symptom onset. The goal is to see if minocycline reduces brain inflammation and helps more people regain independence by 90 days.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
RECRUITINGWuhan, Hubei, 430000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Minocycline (an antibiotic)
What this could lead to
If it works, this could point toward a simple, widely available treatment to improve recovery and reduce disability after a severe stroke.
What could go wrong
This is a mid-stage trial with 234 participants, so results are not yet proven. Minocycline may not improve outcomes and could have side effects like dizziness or nausea.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.